Abstract
Nicotine increases serotonin release in the brain and symptoms of nicotine withdrawal may be modulated by diminished serotonergic neurotransmission. The promoter region of the serotonin transporter gene, solute carrier family neurotransmitter transporter member 4 (SLC6A4), contains a functional tandem repeat polymorphism. The long (L) variant is more actively transcribed than the short (S) variant and is associated with a higher serotonin uptake. To investigate the potential role of this polymorphism for smoking behavior, SLC6A4 genotypes were determined in two different studies, the SMOKING GENES case–control study (470 current smokers and 419 subjects who had never smoked) and the cross-sectional Ludwigshafen risk and cardiovascular health (LURIC) study (777 current smokers and 1178 subjects who had never smoked). In the SMOKING GENES case–control study, SLC6A4 genotype frequencies were not statistically different between smokers (LL: 30.9%; LS: 46.8%; SS: 16.4%) and non-smokers (LL: 36.3%; LS: 41.8%; SS: 14.3%; P=0.13). Similar results were obtained in the cross-sectional LURIC study (smokers: LL, 36.5%, LS, 45.6%, SS, 17.9%; non-smokers: LL, 33.6%, LS, 48.9%, SS, 17.6%; P=0.33). SLC6A4 genotypes were furthermore not associated with Fagerstrom Tolerance Questionnaire score, packyears, number of cigarettes smoked per day or previous attempts to quit smoking. We conclude that the SLC6A4 promoter polymorphism is not a major determinant of smoking behavior in Caucasian.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- DRD:
-
dopamine receptor
- L:
-
long
- LURIC:
-
Ludwigshafen Risk and Cardiovascular Health
- S:
-
short
- SLC6A3:
-
solute carrier family neurotransmitter transporter member 3
- SLC6A4:
-
solute carrier family neurotransmitter transporter member 4
References
Giordanio JM . Cigarette smoking and vascular disease. In: Sidawy AN, Sumpio BE, De Palma (eds). The Basic Science of Vascular Disease. Futura Publishing: New York, 1997, pp 471–475.
True WR, Heath AC, Scherrer JF, Waterman B, Goldberg J, Lin N et al. Genetic and environmenal contributions to smoking. Addiction 1997; 92: 1277–1287.
Arinami T, Ishiguro H, Onaivi ES . Polymorphisms in genes involved in neurotransmission in relation to smoking. Eur J Pharmacol 2000; 410: 215–226.
Carmelli D, Swan GE, Robinette D, Fabsitz R . Genetic influence on smoking – a study of male twins. N Engl J Med 1992; 327: 829–833.
Heath AC, Madden PA, Slutske WS, Martin NG . Personality and the inheritance of smoking behavior: a genetic perspective. Behav Genet 1995; 25: 103–117.
Schloss P, Williams DC . The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 1998; 12: 115–121.
Murphy DL, Lerner A, Rudnick G, Lesch KP . Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interven 2004; 4: 109–123.
Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS et al. Antidepressant and cocain-sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proc Natl Acad Sci USA 1993; 90: 2542–2546.
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527–1531.
Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621–2624.
Murakami F, Shimomura T, Kotani K, Ikawa S, Nanba E, Adachi K . Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese. J Hum Genet 1999; 44: 15–17.
Ohara K, Nagai M, Suzuki Y, Ochiai M . Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene. Psychiatry Res 1998; 81: 277–279.
Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH . No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry 1997; 2: 224–226.
Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B et al. An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms. Mol Psychiatry 1998; 3: 449–451.
Bergen AW, Korczak JF, Weissbecker KA, Goldstein AM . A genome-wide search for loci contributing to smoking and alcoholism. Genet Epidemiol 1999; 1: 55–60.
Ishikawa H, Ohtsuki T, Ishiguro H, Yamakawa-Kobayashi K, Endo K, Lin YL et al. Association between serotonin transporter gene polymorphism and smoking among Japanese Males. Cancer Epidemiol Biomarkers Prev 1999; 8: 831–833.
Kremer I, Bachner-Melman R, Reshef A, Broude L, Nemanov L, Gritsenko I et al. Association of the serotonin transporter gene with smoking behavior. Am J Psychiatry 2005; 162: 924–930.
Gerra G, Garofano L, Zaimovic A, Moi G, Branchi B, Bussandri M et al. Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am J Med Genet B 2004; 135B: 73–78.
Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR et al. The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev 1998; 7: 253–255.
Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG . Replication validity of genetic association studies. Nat Genet 2001; 29: 306–309.
Hegele RA . SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol 2002; 22: 1058–1061.
Campbell H, Rudan I . Interpretation of genetic association studies in complex disease. Pharmacogenomics J 2002; 2: 349–360.
MacKenzie A, Quinn J . A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 1999; 96: 15251–15255.
Heatherton HF, Kozlowski LT, Frecker RC, Fagerstrom KO . The Fagerstrom Test for nicotin dependence: a revision of the Fagerstrom Tolerance Questionaire. Br J Addict 1991; 9: 1119–1127.
Winkelmann BR, Marz W, Boehm BO, Zotz R, Hager J, Hellstern P et al. Rationale and design of the LURIC study – a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001; 2: 1–73.
Acknowledgements
We thank Biomedical scientist Renate Jahrbacher and Biomedical scientist Ernestine Marx-Neuhold for helpful comments and critical evaluation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trummer, O., Köppel, H., Wascher, T. et al. The serotonin transporter gene polymorphism is not associated with smoking behavior. Pharmacogenomics J 6, 397–400 (2006). https://doi.org/10.1038/sj.tpj.6500389
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500389
Keywords
This article is cited by
-
Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus
Scientific Reports (2020)
-
Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions
Molecular Psychiatry (2016)
-
SLC6A4STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study
BMC Genetics (2014)
-
Association between the STin2 VNTR polymorphism and smoking behavior in oral cancer patients and healthy individuals
Clinical and Experimental Medicine (2012)
-
Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour
Journal of Genetics (2011)